Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

States argue that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information ...

New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information after the genetic testing company filed for bankruptcy in March. Twenty ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

The states argue that customers should have control over their personal information, which cannot be treated like ordinary ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of ...

We cannot overstate the threat to this nation and to people individually." 23andMe's bankruptcy is currently pending following lawsuits filed by state attorneys general and ongoing privacy concerns.

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...